Prostatic involution after intraprostatic injection of cobra toxin

Area of Science:

• Urology
• Toxicology
• Cell Biology

Background:

• Benign prostatic hyperplasia (BPH) is a common condition in aging men.
• Current treatments for BPH have limitations and side effects.
• Novel therapeutic agents for prostate conditions are under investigation.

Purpose of the Study:

• To compare the effects of intraprostatic cobra cardiotoxin D and botulinum toxin type A on prostate structure in a rat model.
• To evaluate the potential of cardiotoxin D as a treatment for prostate conditions.

Main Methods:

• 18 Sprague-Dawley rats were divided into three groups (n=6 each).
• Groups received intraprostatic injections of saline, botulinum toxin type A, or cobra cardiotoxin D.
• Prostate glands were analyzed after 14 days for weight, histology, apoptosis, and cell proliferation.

Main Results:

• Cardiotoxin D significantly reduced prostate weight compared to botulinum toxin A and saline controls.
• Both cardiotoxin D and botulinum toxin A induced prostatic atrophy and increased apoptotic cells.
• Botulinum toxin A increased proliferating cells, while cardiotoxin D did not, and only botulinum toxin A caused body weight loss.

Conclusions:

• Intraprostatic cobra cardiotoxin D induces significant prostatic atrophy and weight reduction.
• Cardiotoxin D demonstrates a greater effect on prostate weight reduction than botulinum toxin A.
• Cardiotoxin D shows no systemic effects and may have a prolonged impact on prostate cell proliferation.